Cutler Group LP Karuna Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Oct 25, 2022
BUY
$123.79 - $277.42 $185,685 - $416,130
1,500 New
1,500 $33,000
Q3 2020

Oct 27, 2020
SELL
$71.31 - $109.74 $606,135 - $932,790
-8,500 Reduced 96.59%
300 $1,000
Q2 2020

Jul 22, 2020
SELL
$62.14 - $117.21 $211,276 - $398,514
-3,400 Reduced 27.87%
8,800 $14,000
Q1 2020

May 07, 2020
BUY
$60.41 - $115.92 $737,002 - $1.41 Million
12,200 New
12,200 $167,000

Others Institutions Holding KRTX

# of Institutions
13
Shares Held
333K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email